Literature DB >> 15550407

Revisiting phenobarbital for epilepsy.

Rajendra Kale, Emilio Perucca.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15550407      PMCID: PMC529354          DOI: 10.1136/bmj.329.7476.1199

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Does withdrawal of different antiepileptic drugs have different effects on seizure recurrence? Further results from the MRC Antiepileptic Drug Withdrawal Study.

Authors:  D Chadwick
Journal:  Brain       Date:  1999-03       Impact factor: 13.501

Review 2.  Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures.

Authors:  S Taylor; C Tudur Smith; P R Williamson; A G Marson
Journal:  Cochrane Database Syst Rev       Date:  2001

3.  Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group)

Authors:  A T Feksi; J Kaamugisha; J W Sander; S Gatiti; S D Shorvon
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

4.  Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India.

Authors:  D K Pal; T Das; G Chaudhury; A L Johnson; B G Neville
Journal:  Lancet       Date:  1998-01-03       Impact factor: 79.321

5.  Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study.

Authors:  K S Mani; G Rangan; H V Srinivas; V S Srindharan; D K Subbakrishna
Journal:  Lancet       Date:  2001-04-28       Impact factor: 79.321

Review 6.  Carbamazepine versus phenobarbitone monotherapy for epilepsy.

Authors:  C Tudur Smith; A G Marson; P R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 7.  Phenobarbital for the treatment of epilepsy in the 21st century: a critical review.

Authors:  Patrick Kwan; Martin J Brodie
Journal:  Epilepsia       Date:  2004-09       Impact factor: 5.864

8.  Comparison of antiepileptic drugs on cognitive function in newly diagnosed epileptic children: a psychometric and neurophysiological study.

Authors:  Y J Chen; W M Kang; W C So
Journal:  Epilepsia       Date:  1996-01       Impact factor: 5.864

  8 in total
  9 in total

1.  The pharmacology of new antiepileptic drugs: does a novel mechanism of action really matter?

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2011-11-01       Impact factor: 5.749

2.  Phenobarbital for epilepsy: much is still to be learnt.

Authors:  Edward H Reynolds
Journal:  BMJ       Date:  2005-04-09

3.  Treatment of epilepsy in developing countries.

Authors:  Emilio Perucca
Journal:  BMJ       Date:  2007-06-09

4.  Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial.

Authors:  Selina H Banu; Moshrat Jahan; Umme Kulsum Koli; Saadia Ferdousi; Naila Z Khan; Brian Neville
Journal:  BMJ       Date:  2006-12-04

5.  Undue regulatory control on phenobarbital--an important yet overlooked reason for the epilepsy treatment gap.

Authors:  Devender Bhalla; Hasan Aziz; Donna Bergen; Gretchen L Birbeck; Arturo Carpio; Esper Cavalheiro; Phetvongsinh Chivorakoun; J Helen Cross; Dismand Houinato; Charles R Newton; Peter Odermatt; Sangeeta Ravat; Erich Schmutzhard; Pierre-Marie Preux
Journal:  Epilepsia       Date:  2015-04       Impact factor: 5.864

6.  Phenobarbital for childhood epilepsy: systematic review.

Authors:  Deb K Pal
Journal:  Paediatr Perinat Drug Ther       Date:  2006-05

Review 7.  Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications.

Authors:  Fakher Rahim; Reza Azizimalamiri; Mehdi Sayyah; Alireza Malayeri
Journal:  J Exp Pharmacol       Date:  2021-03-11

8.  Evading Seizures: Phenobarbital Reintroduced as a Multifunctional Approach to End-of-Life Care.

Authors:  Helen Senderovich; Sarah Waicus; Keisa Mokenela
Journal:  Case Rep Oncol       Date:  2022-03-10

9.  Childhood epilepsy: Management in resource-limited setting.

Authors:  Chhaya Valvi; Subhashchandra Daga; Ujwala Kabade; Madhuri Agarwal
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.